As CSO at Miskawaan Health Group, John oversees scientific aspects for developing novel and advanced therapies. He has a PhD in Cell Biology and Virology from the University of Vienna, and over 25 years of experience in biotech and MedTech R&D. John's core competencies include molecular and cellular biology, cell line development, cell encapsulation, virology, microbiology, and GMP manufacturing. He has applied his skills to various areas of application, such as cell and gene therapy, viral vectors and micro-vesicles, microbiome adjustment, oncology, medical devices, and probiotics. He is author on more than 30 peer-reviewed scientific publications as well as multiple patents, grants and fund-raising activities in his field of expertise. Prior to joining Miskawaan in Thailand, John was a Senior Director at Celligenics in Singapore and COO at Austrianova (Singapore, Thailand and Germany). He was instrumental in developing and commercializing a live cell encapsulation platform technology for medical purposes as well as use in functional foods and cosmeceuticals. He is passionate about advancing the field of cell therapy, cell related regenerative technologies and evidence-based natural products to create value and impact for medicine and longevity.